Fetal Echocardiography in Pregnancies of Women with Congenital Heart Disease - Clinical Utility and Limitations[1]

Women with important cyanotic or uncyanotic, operated or unoperated congenital heart disease (CHD) have been shown to carry an inherent risk during pregnancy for themselves and for their fetus. Obstetrical and fetal echocardiography has recently been upgraded by new technical developments in ultrasound machines. These improvements have increased the detection rate of congenital malformations and cardiac anomalies which ranged in the past between 4 and 60 % for significant anomalies. Obesity or an unfavourable position of the fetus may, however, obscure the imaging quality and cause limitations to visualise the fetal heart from different angles and thus prevent the detection of anomalies. In addition, several cardiac anomalies develop throughout pregnancy and may not yet be present at an early date of screening. While the risk for a congenital cardiac malformation (CCM) in a normal population is 0.8 - 1 %, the recurrence rate for CCM increases to 2 to 3 % when a previous child has been affected but will become significantly higher when genetically determined anomalies have affected a family member or when the pregnant woman (5.8 %) has CHD. The aim of fetal screening in women with CCM is to ascertain normal intrauterine growth, to exclude fetal CHD and/or to ascertain a malformation or arrhythmia which has been suspected during an obstetrical screening. The acquired detailed echocardiographic knowledge of the malformation or arrhythmia allows the explanation of a CCM to the future parents, to present therapeutic options during pregnancy or after birth and to plan delivery in a tertiary center that provides early cardiovascular and/or catheter interventions and disposes of intensive care facilities for affected newborns. Under certain conditions, termination can be discussed in early pregnancy. Very recent publications have shown how important a prenatal diagnosis can become in a new-born with transposition of the great arteries and a very restrictive foramen ovale (Circulation 1999). Therapeutic measures in the fetus have been attempted with very Iimited success so far; successful life saving treatment does, however, exist for fetal arrhythmias. In conclusion: Fetal echocardiography has become an important analytical tool in high-risk pregnancies, especially when parents are affected by a CCM. The examination is safe and can be performed with a high predictive and sensitivity rate.

Pregnancy - fetal ECHO - Congenital cardiac malformation - Screening

References

• 1 Kirkland C J. The impact of pregnancy on the woman with congenital heart disease: considerations for intrapartum nursing care.  NAACOGS Clin Issu Perinat Womens Health Nurs. 1992;  3 429-442
• 2 Perloff J K. Congenital heart disease and pregnancy.  CIin.Cardiol.. 1994;  17 579-587
• 3 Burn J, Brennan P, Little J. et al . Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study [see comments].  Lancet. 1998;  351 311-316
• 4 Clark E B. Mechanisms of the pathogenesis of congenital cardiac malformations. In: Pierpont, ME, Moeller, JH (eds) Genetics of cardiovascular disease. Boston; MA, Martinus Nizhoff 1986
• 5 Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy in cyanotic congenital heart disease. Outcome of mother and foetus.  Circulation. 1994;  89 2673-2676
• 6 Schmaltz A A, Neudorf U, Winkler U H. Outcome of pregnancy in women with congenital heart disease.  Cardiol Young. 1999;  9 88-96
• 7 Sciscione A C, Callan N A. Congenital heart disease.  Cardiol Clin. 1993;  11 701-709
• 8 Kaemmerer H, Niesert S, Daniel W G, Lichtlen P R, Kallfelz H C. [Pregnancy and congenital heart failure].  Z Kardiol. 1994;  83 208-214
• 9 Whittemore R, Hobbins J C, Engle M A. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease.  Am J Cardiol. 1982;  50 641-651
• 10 Elkayam U, Gleicher N. Congenital heart disease and pregnancy.  Heart Failure. 1993;  46-50 2000
• 11 Wooley C F, Sparkley E H. Congenital heart disease, Heritable Cardiovascular Congenital heart disease and Pregnancy.  Progress in Cardiovascular Disease. 1992;  35 41-60
• 12 Presbitero P, Rabajoli F, Somerville J. Pregnancy in patients with congenital heart disease.  Schweiz Med Wochenschr. 1995;  125 311-315
• 13 Hadlock F P, Harrist R B, Carpenter R J, Deter R L, Park S K. Sonographic estimation of fetal weight. The value of femur length in addition to head and abdomen measurements.  Radiology. 1984;  150 535-540
• 14 Fouron J C, Skoll A, Sonesson S E, Pfizenmaier M, Jaeggi E, Lessard M. Relationship between flow through the fetal aortic isthmus and cerebral oxygenation during acute placental circulatory insufficiency in ovine fetuses.  Am J Obstet Gynecol. 1999;  181 1102-1107
• 15 Spencer K. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.  Br J Obstet Gynaecol. 1999;  106 1267-1293
• 16 de Graaf I M, Pajkrt E, Bilardo C M, Leschot N J, Cuckle H S, van Lith J M. Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency.  Prenat Diagn. 1999;  19 458-462
• 17 Allan L D, Santos R, Pexider T. Anatomical and echocardiographic correlates of normal cardiac morphology in the late first trimester fetus.  Heart. 1997;  77 68-72
• 18 Allan L D. Foetal congenital heart disease: diagnosis and management.  Curr Opin Obstet Gynecol. 1994;  6 45-49
• 19 Wyllie J, Wren C, Hunter S. Screening for fetal cardiac malformations.  Br Heart J. 1994;  71 20-27
• 20 Crane J, LeFevre M L, Winborn R C. et al . A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses. The RADIUS Study Group [see comments].  Am J Obstet Gynecol. 1994;  171 392-399
• 21 Bull C. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK.  British Paediatric Cardiac Association. Lancet. 1999;  354 1242-1247
• 22 Stumpfen I, Stumpflen A, Wimmer M, Bernaschek G. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease [see comments].  Lancet. 1996;  348 854-857
• 23 Yagel S, Weissman A, Rotstein Z. et al . Congenital heart defects: Natural course and in utero development.  Circulation ER. 1997;  96 550-555
• 24 Buskens E, Grobbee D E, Frohn-Mulder I M. et al . Efficacy of routine fetal ultrasound screening for congenital heart disease in normal pregnancy.  Circulation. 1996;  94 67-72
• 25 Daubeney P E, Sharland G K, Cook A C, Keeton B R, Anderson R H, Webber S A. Pulmonary atresia with intact ventricular septum: impact of fetal echocardiography on incidence at birth and postnatal outcome. UK and Eire Collaborative Study of Pulmonary Atresia with Intact Ventricular Septum.  Circulation. 1998;  98 562-566
• 26 Hunter S, Heads A, Wyllie J, Robson S. Prenatal Diagnosis of Congenital Heart Disease in the Northern Region of England. Heart 2000: (in press)
• 27 Bonnet D, Coltri A, Butera G. et al . [Prenatal diagnosis of transposition of great vessels reduces neonatal morbidity and mortality].  Arch Mal Coeur Vaiss. 1999;  92 637-640

1 Presented at the WATCH-Symposium of the Swiss Society of Cardiology within the 3^rd Joint Meeting of the Austrian, German and Swiss Society for Thoracic and Cardiovascular Surgery; Luzern, Switzerland, February 9 - 12, 2000

2 Fetal Biophysical Profile scanning: In: Manning FA; ed. Fetal Medicine: Principles and practice. Norwalk Conn.: Appelton 8 Lange; 1995.